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Abstract
Background: More than 3 years since the last Zika virus (ZIKV) outbreak in Brazil, researchers are still deciphering
the molecular mechanisms of neurovirulence and vertical transmission, as well as the best way to control spread of
ZIKV, a flavivirus. The use of pesticides was the main strategy of mosquito control during the last ZIKV outbreak.
Methods: We used vesicular stomatitis virus (VSV) tagged with green fluorescent protein (GFP) as our prototypical
virus to study the impact of insecticide pyriproxyfen (PPF). VZV-GFP infected and uninfected Jurkat, HeLa and
trophoblast cells were treated with PPF and compared to untreated cells (control). Cell viability was determined by
the MTT assay. Cell morphology, presence of extracellular vesicles (EVs), virus infection/GFP expression as well as
active mitochondrial levels/localization were examined by confocal microscopy.
Results: PPF, which was used to control mosquito populations in Brazil prior to the ZIKV outbreak, enhances VSV
replication and has cell membrane-altering properties in the presence of virus. PPF causes enhanced viral
replication and formation of large EVs, loaded with virus as well as mitochondria. Treatment of trophoblasts or HeLa
cells with increasing concentrations of PPF does not alter cell viability, however, it proportionately increases Jurkat
cell viability. Increasing concentrations of PPF followed by VSV infection does not interfere with HeLa cell viability.
Both Jurkats and trophoblasts show proportionately increased cell death with increased concentrations of PPF in
the presence of virus.
Conclusions: We hypothesize that PPF disrupts the lipid microenvironment of mammalian cells, thereby interfering
with pathways of viral replication. PPF lowers viability of trophoblasts and Jurkats in the presence of VSV, implying
that the combination renders immune system impairment in infected individuals as well as enhanced vulnerability
of fetuses towards viral vertical transmission. We hypothesize that similar viruses such as ZIKV may be vertically
transmitted via EV-to-cell contact when exposed to PPF, thereby bypassing immune detection. The impact of
pesticides on viral replication must be fully investigated before large scale use in future outbreaks of mosquito
borne viruses.
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control
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Background
Mosquito borne viral diseases such as Dengue fever,
West Nile virus encephalitis, Chikungunya, Yellow fever,
and Zika, are diseases that present treatment challenges.
They also create a major public health crisis when they
are detected in epidemic proportions. In the absence of
vaccines and antiviral drugs for most of these viruses, a
major focus remains on mosquito or vector eradication
to limit disease/virus transmission. The elimination of
pathogen transmitting mosquito species Aedes aegypti
and Aedes albopictus has many challenges. Aedes finds a
natural habitat in crowded tropical cities and can eas-
ily propagate indoors and/or outdoors in small bodies
of water [1]. The initial approach in the United States
in the 2015/2016 Zika virus (ZIKV) outbreak was to
spray insecticides and larvicides in all areas suspected
of local transmission [2]. That strategy appears to
have reduced mosquito numbers, thereby halting the
spread of ZIKV. The outlook was worse for hard-hit
Brazil, where the inefficient and largely ineffective im-
plementation of a comprehensive Aedes aegypti con-
trol plan did not prevent the massive outbreak of
ZIKV that was reported [3].
It has been suggested that in Brazil, one of the agents
used for mosquito control was the pesticide, pyriproxy-
fen (2-[1-methyl-2-(4-phenoxyphenoxy) ethoxy] pyridine
or PPF for short) [4]. Questions remain about the impact
of using PPF as a means of mosquito control. To date,
no documented studies have explored the possibility that
PPF could interfere with mammalian cell membrane
structure and function, thereby interfering with viral
replication as well as mode of transmission. The life
cycle of enveloped cytoplasmic viruses, which include
orthomyxovirus (e.g. VSV) and flaviviruses (e.g. ZIKV),
is dependent on cellular lipid metabolism, which in turn
influences the steps of viral attachment, fusion and bud-
ding [5]. Host lipid-modifying pathways have been
shown to be utilized by distantly related positive-sense
RNA viruses for formation of replication sites [6]. Bud-
ding of newly replicated VSV is dependent on the integ-
rity of membrane microdomains [7]. Although PPF is
generally recognized as safe, we hypothesize that PPF
could disrupt the lipid microenvironment of mammalian
cells, thereby interfering with pathways of viral replica-
tion when those cells are infected. It is worth noting that
the brain, which can be targeted by viruses, is largely
composed of lipids [8–10]. The chemical structure of
PPF mimics insect juvenile hormone (JH), is lipid-
soluble, and causes serious disruptions in hormone path-
ways, affecting development and reproduction of insects,
insect behavior, pheromone production as well as adult
morphogenesis [11]. The lipophilic nature of PPF hints
at a potential influence on membrane lipid composition
of cells that are exposed to it, thereby influencing
membrane processes such as formation of extracellular
vesicles (EV), viral entry, replication and budding.
We have tested the effects of PPF on viability of: (a)
primary human placental trophoblasts, which play a crit-
ical role as a physical barrier against teratogenic virus
transmission [12, 13]; (b) HeLa cell line, derived from
uterine epithelial tissue, which is affected by viruses and
can utilize non-conventional cell-to-cell transmission
[14] and (c) Jurkat cell line, derived from human lym-
phocytes (T-cells), which was chosen due to its import-
ance as immune system mediator and due to previously
shown resistance to toxic/insecticidal compounds [15].
Cells were infected with a prototypical virus, the Vesicu-
lar Stomatitis Virus (VSV) at MOI of 1.0 for viability as-
says and at MOI of 0.001 for immunostaining. VSV is
considered teratogenic and neurotropic [16, 17]. Al-
though VSV infections are mainly asymptomatic in
humans, it can cause flu-like symptoms and has been
shown to be capable of infecting brain cells and causing
encephalitis [18].
Our results show a preferential impact of PPF on virus
infected cells. In the absence of viral infection, treatment
of trophoblasts or HeLa cells with increasing concentra-
tions of PPF does not alter cell viability. Treatment of
Jurkat cells with PPF, however, proportionately increased
Jurkat cell viability. Similar results using an antimicro-
bial/insecticidal agent had previously been shown with
Jurkat cells and HeLa cells exposed to scorpion venom
[15]. Increasing concentrations of PPF followed by VSV
infection does not interfere with HeLa cell viability. In
the presence of virus, both Jurkat cells and trophoblasts
show proportionately increased cell death with increased
concentrations of PPF. VSV-GFP infected Jurkat cells
and HeLa cells treated with PPF showed the presence of
EV that were freestanding as well as in contact with
cells. These types of structures could potentially result
in quick transmission of virus among cells within the
host as well as vertical transmission. We show for the
first time that pesticide treatment decreases viability of
infected cells (Jurkat cells and trophoblasts) and pro-
motes increased viral replication in newly detected EVs.
A potential consequence of using a pesticide such as
PPF is its impact on mammalian cell structure, with a
downstream enhancement of replication and transmis-
sion of a virus that is heavily dependent on its host cell
membrane integrity. Further studies using viruses such
as ZIKV are warranted to better understand the impact
of pesticide use on viral replication.
Methods
Cell culture, pesticide treatment and VSV infection
The following human cells were obtained from the
American Tissue Culture Collection: Jurkat (T-cell de-
rived cell line) (ATCC, clone E6–1), HeLa (clone CCL-
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2), and trophoblasts (ATCC, CRL-3271). Trophoblasts
and Jurkat cells were grown in RPMI media (Cellgro,
Fisher Scientific), while HeLa cells were grown in
DMEM media (Cellgro, Fisher Scientific). Both types of
media contained 10% HyClone™ Fetal Bovine Serum
(FBS, Fisher Scientific), supplemented with 1% HyClone™
antibiotic/antimycotic solution (Fisher Scientific) in an
atmosphere of 5% CO2, at 37 °C. For immunostaining
experiments, cells were treated for 12 h with 0.01 μg/mL
of pyriproxyfen (PPF; Sigma-Aldrich), a concentration
equivalent to that used in Brazil to inhibit mosquito
propagation in drinking water. The Control cells were
treated for 12 h with equivalent concentration of PPF
solvent dimethylsulfoxide (DMSO). Infections with VSV-
GFP virus (vesicular stomatitis virus, Indiana strain,
fused with green fluorescent protein, a gift from Dr.
Glen Barber, University of Miami Sylvester Cancer Cen-
ter) were performed as previously described [19]. Briefly,
cells were plated on poly-L-lysine treated glass cover
slips placed on 6-well plates and infected for 16 h with
VSV tagged with green fluorescent protein (VSV-GFP)
without FBS or antimicrobials, at a very low multiplicity
of infection (MOI) of 0.001.
Cell viability (MTT) assay
Cells were seeded at a density of 1 × 104 in 96-well plates
and allowed to settle overnight. Cells were then either not
treated (control) or treated with several concentrations of
PPF (from 0.001 to 10.0 μg/mL) and incubated overnight.
Next day, cells were infected with VSV-GFP at MOI of 1.0
and again incubated overnight. Subsequently, cells were
treated with MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-di-
phenyltetrazolium bromide (Sigma-Aldrich, MO) dis-
solved in PBS (stock solution is 5mg/ml) at a final
concentration of 5 μg/ml. After incubation for approxi-
mately 2 h at 37 °C, 5% CO2, the MTT-treated media was
aspirated from adherent cells (trophoblasts and HeLa
cells), which were subsequently exposed to 200 μl Di-
methyl sulfoxide (DMSO) (Sigma-Aldrich, MO) per well.
Cell density was measured with a microplate-reader at a
wavelength of 570 nm. Suspension cells (Jurkat cells) were
centrifuged at low speed (180xG) and the media was care-
fully aspirated in order not to disturb sedimented cells.
Addition of 200 μl DMSO and a cell density reading at
570 nm followed as above. We compared the viability of
cells treated with PPF and subsequently either uninfected
or infected with VSV-GFP. All experiments were carried
out in multiples of 8. Cell viability percentages were esti-
mated by dividing the absorbance values of treated cells
with that of control cells.
Immunostaining and confocal microscopy
Cells were treated as above with PPF, infected (or not)
with VSV-GFP at a MOI of 0.001and fixed with 4%
formaldehyde (Sigma-Aldrich) for 8 min at room
temperature. Cells were then washed thrice in PBS and
stained with Hoescht 33,258 (Invitrogen) for 5 min in a
humidifying chamber at room temperature. Cells were
washed thrice with PBS and mounted on glass slides
using ProLong Antifade Gold reagent (Invitrogen). HeLa
cells were obtained from ATCC (clone CCL-2), grown
in DMEM media containing 10% HyClone™ FBS supple-
mented with 1% HyClone™ antibiotic/antimycotic solu-
tion, in an atmosphere of 5% CO2 at 37 °C. HeLa cells
were treated with PPF, DMSO and VSV-GFP as de-
scribed above for Jurkat cells. For mitochondria-labeling
experiments, cells were treated with PPF and VSV-GFP
as described above. These cells were subsequently
treated with MitoTracker Orange for 30 min, then fixed
for 10 min with cold methanol at − 20 °C according to
manufacturer’s instructions (Invitrogen). Samples were
examined on a Zeiss LSM880 confocal microscope using
Zen software. The above experiments were performed
three independent times and in triplicate, each time.
Fluorescence profile analysis of VSV-GFP, mitochondria,
nuclear staining and cell morphology were performed
using Zen software (Zeiss).
Results
PPF appears to decrease viability of VSV-GFP infected
trophoblasts and Jurkat cells (Fig. 1)
We conducted viability tests of trophoblasts, HeLa cells
and Jurkat cells treated with varying concentrations of
PPF from 0.001 to 10.0 μg/mL These cells were subse-
quently uninfected or infected with VSV (a prototypical
enveloped virus that replicates in the cytoplasm of cells,
similarly to ZIKV) fused to Green fluorescence protein
(VSV-GFP) at a MOI of 1.0. PPF alone does not appear
to greatly affect viability of trophoblasts, HeLa cells, or
Jurkat cells. Infection with VSV-GFP reduces cell viabil-
ity of all three cell lines. Increasing concentrations of
PPF affects viability of infected trophoblasts. The most
dramatic results are seen with HeLa cells, where cell via-
bility drastically decreases in infected cells. Increasing
the concentration of PPF does not further decrease via-
bility of infected HeLa cells. In the case of infected Jur-
kat cells, increasing concentrations of PPF decreases the
viability of infected cells.
PPF treated cells infected with VSV-GFP show formation
of large extracellular vesicle (EV) filled with virus (Fig. 2)
Based on our hypothesis that PPF disrupts the mem-
brane microenvironment of mammalian cells, thereby
interfering with pathways of viral replication, we exposed
Jurkat cells to PPF in vitro, at concentrations similar to
those used for treatment of drinking water in Brazil.
Control Jurkat cells, untreated with PPF and uninfected
with VSV-GFP are shown in Fig. 2a. As expected, there
Faria Waziry et al. Virology Journal           (2020) 17:93 Page 3 of 8
is a lack of green fluorescence, a marker for the presence
and replication level of virus (Fig. 2ai). Hoecsht staining
reveals presence of nuclei, distinguishing cells (blue
structures, Fig. 2aii) from vesicles, while differential
interference contrast (DIC) microscopy (Fig. 2aiii) re-
veals normal morphology of cells. A merged image of i,
ii and iii (Fig. 2aiv) shows Jurkat cells with normal
morphology, stained nuclei and no virus.
Figure 2b represents cells untreated with PPF and in-
fected with VSV-GFP. As expected, we see the presence
of virus within cells, denoted by green fluorescence
representing VSV-GFP (Fig. 2bi). Host cells supporting
VSV-GFP replication eventually undergo apoptosis, as
revealed by Fig. 2bii, which shows stained nuclei with a
fragmented cell morphology that indicates initiation of
apoptosis. DIC microscopy (Fig. 2biii) further confirms
the apoptotic cell morphology. A merging of images i, ii
and iii reveals the presence of VSV-GFP within nucle-
ated cells (Fig. 2biv), again as expected. A few EVs were
also observed, a phenotype that is normal for Jurkat cells
(shown by white arrow in Fig. 2div) [20]. Some of the
EVs showed the presence of virus, albeit very little, as
reflected by the low intensity of green fluorescence mea-
sured by quantitative confocal microscopy (Fig. 3).
Our next step was to analyze Jurkat cells treated
with PPF and uninfected with virus. As expected,
there is a lack of green fluorescence (Fig. 2ci) and
most cells appear to have normal morphology
(Fig. 2cii, iii, iv). Analysis of PPF-treated and VSV-
GFP infected cells revealed the presence of EVs
packed with virus, as revealed by green fluorescence
(Fig. 2di and iv), with the intensity of green fluores-
cence being proportional to the relative amount of
viruses. The concentrated intensity of green fluores-
cence at the periphery of a large EVs shows high ex-
pression and localization of VSV-GFP at the
membrane of the EV (Fig. 2di and v). The EV is a
structure distinct from the Jurkat cell which is re-
vealed by the presence of blue stained nucleus (yel-
low arrow, Fig. 2dii) adjacent to the EV. DIC
microscopy (Fig. 2diii) shows the normal morphology
of Jurkat cells (yellow arrow) and also depicts the
shape of the large round EV devoid of a nucleus
(red arrow). Jurkat cells appear smaller than the
VSV-filled EV (Fig. 2diii, red arrow) and the two
structures seem interconnected by a tubule (pink
arrow). VSV-GFP packed EV vary in size and shape.
Some of these structures appear attached to cells
Fig. 1 Cell viability (MTT) assay. a Trophoblasts treated with increasing concentrations of PPF (μg/mL). b Trophoblasts infected with VSV-GFP (MOI
of 1.0) and treated with increasing concentrations of PPF (μg/mL). c HeLa cells treated with increasing concentrations of PPF (μg/mL). d HeLa
cells infected with VSV-GFP (MOI of 1.0) and treated with increasing concentrations of PPF (μg/mL). e Jurkat cells treated with increasing
concentrations of PPF (μg/mL). f Jurkat cells infected with VSV-GFP (MOI of 1.0) and treated with increasing concentrations of PPF (μg/mL)
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(pink arrows, Figs. 2diii and dviii) while others are
free standing. Figure 2dv-viii represent a different
field of view and show what appear to be vesicles of
various sizes and shapes, seemingly emerging from
cells (red arrow, Fig. 2dvii), connected by tubules
(pink arrows). Figure 2dviii shows more intense
green fluorescence (corresponding to more viruses)
in attached EVs than in surrounding Jurkat cells
(yellow arrow).
The variety and number of EVs suggests their presence
to be an active process needing the use of mitochondria,
the energy powerhouse of the cell. Our next step was to
investigate the presence of active mitochondria in these
structures, knowing that VSV interacts/co-localizes with
mitochondria [21, 22].
PPF treated cells infected with VSV-GFP accumulate
viruses as well as mitochondria in extracellular vesicles
(EVs) (Fig. 3)
VSV is known to interfere with mitochondria, diverting
cellular energy metabolism towards enhancing viral rep-
lication and ultimately inducing cell apoptosis [22]. We
subjected Jurkat cells treated or untreated with PPF with
or without VSV-GFP infection, to quantitative confocal
microscopy. We assessed the fluorescence intensity of
active mitochondria (orange channel corresponding to
Mito-tracker Orange), VSV-GFP (green channel) and
nuclei (blue channel), with cell membranes (black graph)
representing differential interference contrast. Figure 3a
shows background fluorescence levels of Jurkat cells un-
treated with PPF and uninfected with VSV-GFP. The
Fig. 2 a Jurkat cells untreated with PPF and uninfected with VSV-GFP. b Jurkat cells infected with VSV-GFP. c Jurkat cells treated with PPF. d Jurkat
cells treated with PPF and infected with VSV-GFP. In all cases, panel i is for green fluorescence corresponding to VSV-GFP replication; panel ii shows
Hoecsht 33,258 stained nuclei of Jurkat cells; panel iii shows DIC microscopy of cells; panel iv reveals a merged image of panels i, ii and iii
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inset shows a few cells, stained blue for nuclei and or-
ange for mitochondria, with the profiled fluorescence
pattern representing the cell highlighted within the red
box. As expected, there is a lack of green fluorescence.
Orange fluorescence represents an uneventful state for
the mitochondria. The peak in blue fluorescence repre-
sents nuclei of healthy cells, while the black graph repre-
sents structural integrity of the cell membrane.
Figure 3b and c both show PPF treated cells unin-
fected with virus, with the fluorescence profile represent-
ing the cell highlighted by the red box. The fluorescence
profile seen in 3B is different from that seen in 3A and
is likely an effect of PPF on the individual Jurkat cells.
Figure 3c shows disturbed cell membrane (black graph)
suggestive of apoptotic cell morphology (see inset), while
Fig. 3b profiles an intact cell. Fluorescence analysis of
cells untreated with PPF and infected with VSV-GFP
showed cells filled with virus. When a large, green cell
representing a Jurkat cell with VSV-GFP was analyzed
by quantitative confocal microscopy (Fig. 3d), we saw vi-
ruses (green channel) co-localizing with nuclei (blue
channel) and also with mitochondria (orange channel).
Mitochondria (Fig. 3d) showed normal fluorescence,
similar to the orange fluorescence profiles in Fig. 3a, b
and c, implying background levels of engagement during
VSV-GFP replication in Jurkat cells untreated with PPF.
PPF treated cells infected with VSV-GFP showed pres-
ence of virus within cells and EVs (Fig. 3e and f). Fluores-
cence analysis of a large EV (see inset, Fig. 3e) that
appears attached to a cell, reveals presence of viruses
(green channel), mitochondria (orange channel), and cell
membrane (black graph), but no nuclear staining (blue
channel), since the EVs are devoid of nuclei. The distribu-
tion of VSV-GFP inside these large EVs is very unusual,
showing pockets of virus accumulated inside the vesicles
as well as at the periphery or vesicle surface (quantitative
analysis of Fig. 2di). The accumulated virus pockets within
the Jurkat cells are also rich in mitochondria, with which
the virus is co-localizing. Figure 3f shows the fluorescence
profile of the cell (shown within the insert) attached to the
large EV that was analyzed in Fig. 3e. Fluorescence ana-
lysis of this cell, treated with PPF and infected with virus
reveals co-localization of nuclei (blue channel) and mito-
chondria (orange channel), with green fluorescence above
the background levels seen in cells uninfected with virus
(Figs. 3a, b and c). Higher green fluorescence in EVs (Fig.
3e) suggests higher viral load compared to cells untreated
with PPF (Fig. 3d).
Discussion
Investigators have shown the presence of EVs in HIV in-
fected cells, enabling direct EV-to-cell transmission of
Fig. 3 Fluorescence profile of VSV-GFP (green channel), nuclei (blue channel), mitochondria (orange channel) and cell membrane morphology
(black graph). Jurkat cells were analyzed by quantitative confocal microscopy. a Control Jurkat cells untreated with PPF and uninfected with VSV-
GFP. b cells treated with PPF alone, with fluorescence profile of an intact cell (shown within the red box in the inset). c cells treated with PPF
alone with fluorescence profile of an apoptotic cell (shown within the red box in the inset). d cells infected with VSV-GFP at a multiplicity of
infection of 0.001 with fluorescence profile of a cell (shown within the red box in the inset). e and f cells were first treated with PPF, then
infected with VSV-GFP. e shows the fluorescence profile of a large EV (shown within the red box in the inset), while f shows the fluorescence
profile of a nearby infected cell
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the virus [23–25]. HIV transmission is faster and more
efficient via EVs which promote direct cell contact [25].
The ability of a teratogenic virus such as VSV or ZIKV
to be similarly transmitted by EVs could be an advantage
in its pathogenesis and ability to infect the fetus. Based
on the lipid-soluble, hormone-like chemical structure of
PPF, we hypothesize that PPF is capable of disrupting
cellular membrane composition and lipid metabolism.
Our observations with VSV infection of PPF treated cells
point to the possibility that formation of EVs might en-
able virus to be transmitted quickly in the presence of
PPF, via EV-to-cell contact, thereby evading immune de-
tection. Such EV-to-cell transmission might also be part
of the mechanisms that allow vertical transmission of
this teratogenic virus. EVs were also shown to be a quick
and efficient mode of transmission in a study of Crypto-
cocci where the authors suggest that EV-mediated com-
munication might represent a novel mechanism of
virulence that might be common in other infectious spe-
cies as well [26]. Our experiments show that cells treated
with PPF alone do not readily form EVs (Figs. 2cii, iii
and iv) and it is possible that PPF exposure by itself does
not affect normal cellular functions [27]. However, an
unusual behavior was observed when PPF-exposed cells
were infected with VSV. We observed formation of large
EVs containing mitochondria as well as high levels of
VSV. We postulate that PPF exposure alters normal cel-
lular membrane behavior in the presence of VSV. The
concept that PPF can induce our immune cells to over-
express EVs that support enhanced viral replication is
troubling. Could these EVs bypass the immune system
and enable vertical transmission of viruses? Is this the
reason why Northeast Brazil with the inordinately high
number of microcephalic infants and high incidence of
larvicide usage in drinking water supplies [28] showed a
higher rate of ZIKV-associated microcephaly than other
parts of Brazil or anywhere else in the world? We cannot
conclusively say. However, our results warrant a closer
look at PPF and possibly other pesticides and their im-
pact on our cells and on viral replication, especially that
of mosquito borne viruses such as ZIKV. We hope to
explore PPF treatment of VSV-GFP infected cells using
HeLa cells and trophoblasts.
Conclusions
Keeping in mind the potential undesirable and even
harmful side effects of PPF, it is important to explore al-
ternative options for mosquito eradication until the
underlying mechanisms of pesticide alteration of the
lipid microenvironment of mammalian cells is eluci-
dated. These options may include the genetically modi-
fied (GM) mosquito species, such as the Oxitec
mosquito [29], the soil bacterium Bti (Bacillus thurin-
giensis serotype israelensis), which is a mosquito
larvicide [30] and Wolbachia-infected mosquitoes, which
do not support replication of ZIKV, WNEV, Chikun-
gunya virus and DENV, potentially reducing outbreaks
due to these viruses [31–33].
It may not be possible to completely prevent the next
mosquito-borne viral outbreak. However, proactive on-
going and ecological mosquito control programs will
prove effective for the minimization of detrimental out-
comes. We need to rigorously and scientifically address
whether pesticides can potentially alter our cells and fa-
cilitate the vertical transmission of a teratogenic patho-
gen, such as ZIKV. A recent study demonstrated the use
of a network-based model using an integrative systems
biology approach as a screening step in the assessment
of potential neurotoxicity of chemicals, utilizing PPF as
an example [34]. The authors of that study claim low
cost and speed of analysis as factors in favor of their ap-
proach. Regardless of the methodology used to screen
pesticides prior to their use, one must now be wary of
their impact on human cells, specifically, human cell
membrane lipid composition, which in turn, could im-
pact viral replication as shown in the present study.
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